Expanded label sought for 177Lu-PSMA-617 in prostate cancer: about time

[Maxone73]

I have already done the taxane part and I would like to see how 177Lu performs as first line...but this is also interesting, it seems more effective than a change in ARPI in castration resistant setting

"Data also showed that a PSA decline of at least 50% was more than 2.5 times more frequent with 177Lu-PSMA-617 than with a change in ARPI. Specifically, a PSA decline greater than 50% was observed in 57.6% of patients who received 177Lu-PSMA-617, vs 20.4% of patients who received a change in ARPI."

urologytimes.com/view/expan...

[APK3]

0.07 on your last PSA. Outstanding congrats.

[Maxone73 in reply to APK3]

Well, thank you! I hope it will last